Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest ORIGINAL CONTRIBUTION Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest A Randomized Trial Theresa M. Olasveengen, MD Context Intravenous access and drug administration are included in advanced car- Kjetil Sunde, MD, PhD diac life support (ACLS) guidelines despite a lack of evidence for improved outcomes. Epinephrine was an independent predictor of poor outcome in a large epidemiologi- Cathrine Brunborg, MSc cal study, possibly due to toxicity of the drug or cardiopulmonary resuscitation (CPR) Jon Thowsen interruptions secondary to establishing an intravenous line and drug administration. Petter A. Steen, MD, PhD Objective To determine whether removing intravenous drug administration from an ACLS protocol would improve survival to hospital discharge after out-of-hospital Lars Wik, MD, PhD cardiac arrest. Design, Setting, and Patients Prospective, randomized controlled trial of consecu- NTRAVENOUS ACCESS AND DRUG AD- tive adult patients with out-of-hospital nontraumatic cardiac arrest treated within the emer- ministration are integral parts of gency medical service system in Oslo, Norway, between May 1, 2003, and April 28, 2008. cardiopulmonary resuscitation Interventions Advanced cardiac life support with intravenous drug administration I(CPR) guidelines. Millions of pa- or ACLS without access to intravenous drug administration. tients have received epinephrine dur- ing advanced cardiac life support Main Outcome Measures http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest

Loading next page...
 
/lp/american-medical-association/intravenous-drug-administration-during-out-of-hospital-cardiac-arrest-SutAqa7Bg4

References (47)

Publisher
American Medical Association
Copyright
Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2009.1729
pmid
19934423
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL CONTRIBUTION Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest A Randomized Trial Theresa M. Olasveengen, MD Context Intravenous access and drug administration are included in advanced car- Kjetil Sunde, MD, PhD diac life support (ACLS) guidelines despite a lack of evidence for improved outcomes. Epinephrine was an independent predictor of poor outcome in a large epidemiologi- Cathrine Brunborg, MSc cal study, possibly due to toxicity of the drug or cardiopulmonary resuscitation (CPR) Jon Thowsen interruptions secondary to establishing an intravenous line and drug administration. Petter A. Steen, MD, PhD Objective To determine whether removing intravenous drug administration from an ACLS protocol would improve survival to hospital discharge after out-of-hospital Lars Wik, MD, PhD cardiac arrest. Design, Setting, and Patients Prospective, randomized controlled trial of consecu- NTRAVENOUS ACCESS AND DRUG AD- tive adult patients with out-of-hospital nontraumatic cardiac arrest treated within the emer- ministration are integral parts of gency medical service system in Oslo, Norway, between May 1, 2003, and April 28, 2008. cardiopulmonary resuscitation Interventions Advanced cardiac life support with intravenous drug administration I(CPR) guidelines. Millions of pa- or ACLS without access to intravenous drug administration. tients have received epinephrine dur- ing advanced cardiac life support Main Outcome Measures

Journal

JAMAAmerican Medical Association

Published: Nov 25, 2009

There are no references for this article.